Companies Share Commitment to Continuous Innovation and Enhancing Patient Care
ROCHESTER, N.Y.-Saturday 9 March 2019 [ AETOS Wire ]
(BUSINESS WIRE)-- Carestream Health has signed an agreement with Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, to sell its healthcare information systems (HCIS) business to Philips.
Carestream’s HCIS business unit provides imaging IT solutions to multi-site hospitals, radiology services providers, imaging centers and specialty medical clinics around the world. The business has developed strong customer relationships in attractive, high-growth healthcare segments and is positioned for continued growth and success.
As a result of this acquisition, Philips’ expanded healthcare IT business will feature Carestream’s enterprise imaging platform—including best in class VNA, diagnostic and enterprise viewers, multimedia reporting, workflow orchestrator and clinical, operational
...
Read more »
Views:
547
|
Added by:
africa-live
|
Date:
03.10.2019
|
|
Next Generation SedLine Now Available for Use on Patients 1-18 Years Old in CE Mark Countries
NEUCHATEL, Switzerland-Tuesday 5 March 2019 [ AETOS Wire ]
(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine® brain function monitoring for pediatric patients (1-18 years of age). With this clearance, the benefits of Next Generation SedLine are available for all patients one year old and above in CE mark countries. SedLine helps clinicians monitor the state of the brain under anesthesia with bilateral data acquisition and processing of four leads of electroencephalogram (EEG) signals.
SedLine uses a pediatric-specific signal processing engine to improve performance of Masimo’s processed EEG parameter, the Patient State Index (PSi), when monitoring pediatric patients one year old and above. The use and monitoring of anesthesia on pediatric patients can differ from its use on adults.1-2 Maintaining an appropriat
...
Read more »
Views:
230
|
Added by:
africa-live
|
Date:
03.10.2019
|
|
Latest Release of ThingWorx Introduces Operator Advisor; Enhances Data Sourcing, Analysis, Visualization, and Security
BOSTON-Sunday 10 March 2019 [ AETOS Wire ]
(BUSINESS WIRE) -- PTC (NASDAQ: PTC) today announced the availability of a new version of its award-winning ThingWorx® Industrial Internet of Things (IIoT) solution platform. ThingWorx 8.4 introduces new capabilities, including Operator Advisor, designed to increase productivity of factory workers by simplifying the way critical operational data is collected, synthesized, and delivered. The new version builds on PTC’s unparalled IIoT strategy, further strengthening its robust portfolio of solutions that address real business challenges.
There continues to be significant opportunity for industrial manufacturers to differentiate their product and service offerings and improve worker efficiency across their factory operations by leveraging IIoT technologies. According to a recent report from D
...
Read more »
|
SEOUL -Saturday 9 March 2019 [ AETOS Wire ]
(BUSINESS WIRE)-- ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions.
HBH, a fast-growing privately owned South Korean home medical equipment provider, serves both reimbursed and cash-pay customers of sleep and respiratory care devices. ResMed intends to reach millions more patients through HBH and its wider network of trusted distributor partners.
“ResMed has reaffirmed its leading role in Korea’s CPAP and respiratory care market, and commitment to improving millions of Koreans’ breathing and quality of life,” said Kim Ho Kyun, ResMed Korea’s Sales and Marketing director. “With HBH and our valu
...
Read more »
Views:
179
|
Added by:
africa-live
|
Date:
03.10.2019
|
|
Vedolizumab superior to adalimumab in achieving clinical remission and mucosal healing at week 52 in patients with moderately to severely active ulcerative colitis
OSAKA, Japan -Saturday 9 March 2019 [ AETOS Wire ]
(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from the Phase 3b head-to-head VARSITY study which demonstrated that the gut-selective biologic vedolizumab (Entyvio®) was superior to the anti-tumor necrosis factor-alpha (anti-TNFα) biologic adalimumab (Humira®) in achieving clinical remission* in patients with moderately to severely active ulcerative colitis at week 52. Data showed that 31.3% (n=120/383) of patients receiving vedolizumab intravenous (IV) achieved the primary endpoint of clinical remission compared to 22.5% (n=87/386) of patients treated with adalimumab subcutaneous (SC) at week 52, with the difference being statistically significan
...
Read more »
Views:
260
|
Added by:
africa-live
|
Date:
03.10.2019
|
|
CORAL GABLES, Fla. -Saturday 9 March 2019 [ AETOS Wire ]
(BUSINESS WIRE)-- AerSale®, a global supplier of mid-life aircraft, engines, used serviceable material, and MRO services, announced today that the European Aviation Safety Agency (EASA) and the National Civil Aviation Agency of Brazil (ANAC) have approved the company’s AerTrak™ ADS-B Out system on Boeing 757-200 series aircraft (EASA 10068771) and (ANAC 2018S12-05). Last year, the Federal Aviation Administration (FAA) approved AerTrak for Boeing 737 NG series aircraft (ST04009NY) and Boeing 757-200 series aircraft (ST04011NY) to comply with the FAA’s Automatic Dependent Surveillance-Broadcast (ADS-B) Operations rule.
“This validation reaffirms our commitment to our European and Latin American customers,” said Iso Nezaj, Chief Technical Officer at AerSale. “With the benefit of no certification fees, operators now have a fully-compliant ADS-B Out system available to them. A
...
Read more »
| |